Genetically engineered mouse models in drug discovery research

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 37-54

  Sacca, Rosalba ^a   Engle, Sandra J ^a   Qin, Wenning ^a   Stock, Jeffrey L ^a   McNeish, John D ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Drug discovery; humanized mice; knock in; knock out; phenotype; transgenic

Indexed keywords

ANIMALIA; MUS;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG DEVELOPMENT; DRUG INDUSTRY; GENE TARGETING; HUMAN; MOUSE; MOUSE MUTANT; PHENOTYPE; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; DRUG INDUSTRY; GENE KNOCK-IN TECHNIQUES; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE;

EID: 77449095663     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_3     Document Type: Article

References (58)

1. van der Staay, F. J. and Steckler, T. (2001) Behavioural phenotyping of mouse mutants. Behav Brain Res 125, 3-12. (Pubitemid 33000434)
2. Crawley, J. N. (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835, 18-26. (Pubitemid 29336546)
3. Doevendans, P. A., Daemen, M. J., de Muinck, E. D. and Smits, J. F. (1998) Cardiovascular phenotyping in mice. Cardiovasc Res 39, 34-49. (Pubitemid 28322378)
4. Zambrowicz, B. P. and Sands, A. T. (2003) Knockouts model the 100 best-selling drugs-will they model the next 100? Nat Rev Drug Discov 2, 38-51. (Pubitemid 37361623)
5. Forlino, A., Porter, F. D., Lee, E. J., Westphal, H. and Marini, J. C. (1999) Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem 274, 37923-37931. (Pubitemid 30026860)
6. Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541. (Pubitemid 28240715)
7. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. and Roder, J. C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 90, 8424-8428. (Pubitemid 23277681)
8. Nagy, A., Gocza, E., Diaz, E. M., Prideaux, V. R., Ivanyi, E., Markkula, M., et al. (1990) Embryonic stem cells alone are able to support fetal development in the mouse. Development 110, 815-821.
9. Poueymirou, W. T., Auerbach, W., Frendewey, D., Hickey, J. F., Escaravage, J. M., Esau, L., et al. (2007) F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat Biotechnol 25, 91-99. (Pubitemid 46091512)
10. Zhang, Y.,Muyrers, J. P., Testa, G. and Stewart, A. F. (2000) DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol 18, 1314-1317.
11. Gordon, J. W., Scangos, G. A., Plotkin, D. J., Barbosa, J. A. and Ruddle, F. H. (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 77, 7380-7384. (Pubitemid 11131133)
12. Palmiter, R. D., Chen, H. Y. and Brinster, R. L. (1982) Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell 29, 701-710. (Pubitemid 12024856)
13. Wall, R. J. (2001) Pronuclear microinjection. Cloning Stem Cells 3, 209-220. (Pubitemid 34123563)
14. Gibbs, E. M., Stock, J. L., McCoid, S. C., Stukenbrok, H. A., Pessin, J. E., Stevenson, R. W., et al. (1995) Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95, 1512-1518.
15. Higgins, G. A. and Jacobsen, H. (2003) Transgenic mouse models of Alzheimers disease: phenotype and application. Behav Pharmacol 14, 419-438. (Pubitemid 37176800)
16. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. (Pubitemid 26332733)
17. Cruts, M., Backhovens, H., Wang, S. Y., Van Gassen, G., Theuns, J., De Jonghe, C. D., et al. (1995) Molecular genetic analysis of familial early-onset Alzheimers disease linked to chromosome 14q24.3. Hum Mol Genet 4, 2363-2371.
18. Qin,W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A., Goellner, J. J., et al. (2003) Transgenic model of aldosteronedriven cardiac hypertrophy and heart failure. Circ Res 93, 69-76. (Pubitemid 36859043)
19. Belteki, G., Haigh, J., Kabacs, N., Haigh, K., Sison, K., Costantini, F., et al. (2005) Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res 33, e51.
20. Bockamp, E., Maringer, M., Spangenberg, C., Fees, S., Fraser, S., Eshkind, L., et al. (2002) Of mice and models: improved animal models for biomedical research. Physiol Genomics 11, 115-132.
21. Sutherland, H. G., Kearns, M., Morgan, H. D., Headley, A. P., Morris, C., Martin, D. I., et al. (2000) Reactivation of heritably silenced gene expression in mice. Mamm Genome 11, 347-355. (Pubitemid 30230461)
22. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. and Kemler, R. (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87, 27-45. (Pubitemid 15029925)
23. Koller, B. H.,Hagemann, L. J., Doetschman, T., Hagaman, J. R., Huang, S., Williams, P. J., et al. (1989) Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 86, 8927-8931. (Pubitemid 20010338)
24. Thomas, K. R. and Capecchi, M. R. (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
25. Doetschman, T., Maeda, N. and Smithies, O. (1988) Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc Natl Acad Sci USA 85, 8583-8587. (Pubitemid 19025002)
26. Harris, S. (2001) Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies. Drug Discov Today 6, 628-636. (Pubitemid 32567621)
27. Griffiths, R. J., Smith, M. A., Roach, M. L., Stock, J. L., Stam, E. J., Milici, A. J., et al. (1997) Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice. J ExpMed 185, 1123-1129. (Pubitemid 27136804)
28. Siuciak, J. A., Chapin, D. S., Harms, J. F., Lebel, L. A., McCarthy, S. A., Chambers, L., et al. (2006) Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology 51, 386-396. (Pubitemid 44061894)
29. Siuciak, J. A., McCarthy, S. A., Chapin, D. S., Fujiwara, R. A., James, L. C., Williams, R. D., et al. (2006) Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 51, 374-385. (Pubitemid 44061880)
30. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353.
31. Zhang, S. H., Reddick, R. L., Piedrahita, J. A. and Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471.
32. Beierschmitt, W. P., McNeish, J. D., Griffiths, R. J., Nagahisa, A., Nakane, M. and Amacher, D. E. (2001) Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice. Toxicol Sci 63, 15-21. (Pubitemid 32799019)
33. Seibler, J., Zevnik, B., Kuter-Luks, B., Andreas, S., Kern, H., Hennek, T., et al. (2003) Rapid generation of inducible mouse mutants. Nucl Acids Res 31, e12.
34. Hayashi, S. and McMahon, A. P. (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244, 305-318. (Pubitemid 34450645)
35. Gladue, R. P., Cole, S. H., Roach, M. L., Tylaska, L. A., Nelson, R. T., Shepard, R. M., et al. (2006) The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. J Immunol 176, 3141-3148.
36. Guo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., et al. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5, 101-106. (Pubitemid 29051006)
37. Bian, F., Li, Z., Offord, J., Davis, M. D., McCormick, J., Taylor, C. P., et al. (2006) Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res 1075, 68-80.
38. Zambrowicz, B. P., Turner, C. A. and Sands, A. T. (2003) Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry. Curr Opin Pharmacol 3, 563-570. (Pubitemid 37221139)
39. Zong, X., Eckert, C., Yuan, H., Wahl-Schott, C., Abicht, H., Fang, L., et al. (2005) A novel mechanism of modulation of hyperpolarization-activated cyclic nucleotidegated channels by Src kinase. J Biol Chem 280, 34224-34232. (Pubitemid 41443148)
40. Vander Molen, J., Frisse, L. M., Fullerton, S. M., Qian, Y., Del Bosque-Plata, L., Hudson, R. R., et al. (2005) Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants. Am J Hum Genet 76, 548-560. (Pubitemid 40432163)
41. Okumura, S., Baba, H., Kumada, T., Nanmoku, K., Nakajima, H., Nakane, Y., et al. (2004) Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells. Cancer Sci 95, 131-135. (Pubitemid 38404313)
42. Shrimpton, A. E., Braddock, B. R., Thomson, L. L., Stein, C. K. and Hoo, J. J. (2004) Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype. Clin Genet 66, 537-544. (Pubitemid 39562017)
43. Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., et al. (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281, 22021-22028. (Pubitemid 44181906)
44. Taniguchi, Y., Tonai-Kachi, H. and Shinjo, K. (2006) Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 580, 5003-5008. (Pubitemid 44332369)
45. Kuc, D., Zgrajka, W., Parada-Turska, J., Urbanik-Sypniewska, T. and Turski, W. A. (2008) Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids.
46. Brancho, D., Ventura, J. J., Jaeschke, A., Doran, B., Flavell, R. A. and Davis, R. J. (2005) Role of MLK3 in the regulation of mitogen-activated protein kinase signaling cascades. Mol Cell Biol 25, 3670-3681. (Pubitemid 40559573)
47. Handley, M. E., Rasaiyaah, J., Chain, B. M. and Katz, D. R. (2007) Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity? Int J Exp Pathol 88, 111-126. (Pubitemid 46570078)
48. Waterston, R. H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J. F., Agarwal, P., et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562. (Pubitemid 35477048)
49. Jakobovits, A., Amado, R. G., Yang, X., Roskos, L. and Schwab, G. (2007) From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice. Nat Biotechnol 25, 1134-1143. (Pubitemid 47542248)
50. Gonzalez, F. J. and Yu, A. M. (2006) Cytochrome P450 and xenobiotic receptor humanized mice. Annu Rev Pharmacol Toxicol 46, 41-64. (Pubitemid 43271183)
51. Pascolo, S. (2005) HLA class I transgenic mice: development, utilisation and improvement. Expert Opin Biol Ther 5, 919-938. (Pubitemid 41032849)
52. Shultz, L. D., Ishikawa, F. and Greiner, D. L. (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7, 118-130. (Pubitemid 46174859)
53. Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., et al. (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100, 3175-3182. (Pubitemid 35217065)
54. Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A., et al. (2004) Development of a human adaptive immune system in cord blood celltransplanted mice. Science 304, 104-107. (Pubitemid 38451466)
55. Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106, 1565-1573. (Pubitemid 41208567)
56. Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., et al. (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165, 901-912. (Pubitemid 39129297)
57. Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., et al. (2007) Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 25, 903-910.
58. Hay, D. C., Zhao, D., Fletcher, J., Hewitt, Z. A., McLean, D., Urruticoechea-Uriguen, A., et al. (2008) Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 26, 894-902.